Medical/Pharmaceuticals
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology
LEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology. In the past years, both parties have successful...
2021-07-20 22:54
13492
Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, July 20, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX:02142) announced the appointment of Dr. Yingying Chen as Chief Financial Officer (CFO). Dr. Chen will be responsible for leading the overall management of Finance & Investor Re...
2021-07-20 21:53
13350
Interaxon Partners with Celéri Health to Validate Chronic Pain Intervention
TORONTO, July 20, 2021 /PRNewswire/ -- Interaxon, along with Celéri Health and pain expert Dr.Ronald D. Siegel, is testing a therapeutic intervention to help people better manage their chronic and acute pain. With the prevalence of pain and its multidimensional repercussions, this non-opioid alte...
2021-07-20 21:00
1733
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
* Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND * Samsung Biologics San Francisco R&D center and South Korea headquarters to offer a seamless, end-to-end CDMO service INCHEON, South Korea and SEATTLE, July 20, 2021 /PRNewswire/ -- Sams...
2021-07-20 20:00
2201
Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China
SHANGHAI, July 20, 2021 /PRNewswire/ -- Everest Medicines
2021-07-20 18:42
6224
Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
HONG KONG, July 20, 2021 /PRNewswire/ -- Novotech Health Holdings Pte. Ltd. ("Novotech") joins a historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The "Decent...
2021-07-20 13:10
1711
Juventas Cell Therapy Ltd. Closes Series C Financing to Advance the "Rapid Commercialization and Internationalization" Development Strategy
TIANJIN, China, July 20, 2021 /PRNewswire/ -- Juventas Cell Therapy Ltd., a Chinese biopharmaceutical company announced the close of a $60 million+ Series C financing led by CICC Capital and Oceanpine Capital. The co-investors include Delian Capital and existing investors such as Jiadao Private C...
2021-07-20 10:47
2218
Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE
QINGDAO, China, July 19, 2021 /PRNewswire/ -- On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...
2021-07-20 07:15
1706
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcomes
The company employs real-world data and evidence to accelerate research through targeted site and patient recruitment strategies SANTA CLARA, Calif., July 20, 2021 /PRNewswire/ -- Based on its recent analysis of the global clinical research organization (CRO) market,Frost & Sullivan recognizes l...
2021-07-20 01:47
2246
RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
Patient follow-up completed for the 475-patient global Phase 2/3 study of oral opaganib for severe COVID-19 Top-line results expected in the coming weeks Opaganib, a novel, dual antiviral and anti-inflammatory investigational COVID-19 pill, demonstratedpotent inhibition of Beta and Gamma variant...
2021-07-19 19:21
18118
Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma's Drug Compound pelcitoclax
SUZHOU, China, and ROCKVILLE, Md., July 19, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has entered into a Cooperative ...
2021-07-19 18:41
4512
Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients
* The TALENT study (TALENT) findings, which were presented at the 11th International AIDS Society (IAS) Conference on HIV Science, showed that a two-drug regimen was as effective and safe as multi-drug therapies * TALENT is the world's first phase III clinical trial of the new long-acting HIV...
2021-07-19 16:23
3659
GoTo Group and partners create Indonesia's first dedicated oxygen facility for COVID-19 patients
* "Gotong Royong Oxygen House" to be set up in collaboration with KADIN Indonesia and Samator Group * Oxygen to be piped direct from Samator Group's oxygen production facility, ensuring a reliable and uninterrupted supply * Initiative set to relieve pressure on Jakarta hospitals as the COVID...
2021-07-19 15:16
2124
SonoScape's X5 is aboard to deliver ultrasound imaging in Space
SHENZHEN, China, July 19, 2021 /PRNewswire/ -- On June 17th, the Shenzhou-12 spacecraft consisting of a crew of three was launched into space, taking one step forward to establishChina's Tiangong space station which is under construction in a Low-Earth orbit. Astronauts will stay in space for thr...
2021-07-19 15:10
4144
Parkinson's UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data
LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ -- Parkinson's UK, the largest charitable funder of Parkinson's research inEurope, has announced today that it is using Collaborative Drug Discovery'sCDD Vault informatics system to manage project data from theParkinson's Virtual Biotech, its p...
2021-07-19 14:57
1709
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE
BEIJING, July 19, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of Health & Prevention. PIKA recombinant COVID-19 vaccine is a PI...
2021-07-19 09:00
3631
Bioelectronica Announces Hypercell™ Expansion for Antibody Discovery, Closing of Oversubscribed Series A Financing, Powering Local Hiring Growth and Expansion of Facilities in Reno
RENO, Nev., July 19, 2021 /PRNewswire/ -- Bioelectronica® Corporation ("Bioelectronica") announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in Hypercell™, a new hardware tool that can be used to discover new antibodies using compute...
2021-07-19 08:59
3457
ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials
SHENZHEN, China, July 18, 2021 /PRNewswire/ -- On July 18, 2021, ImmVira inaugurated a pilot-scale production line inShenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials. Leveraging a strat...
2021-07-19 08:30
2130
Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay
SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...
2021-07-16 14:41
37106
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-16 08:00
9202
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 280 media titles]
2026-05-20 09:15Most Read
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
5709
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
5699
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
5541
NYSE Content Update: Exchange Turns 234 Ahead of U.S. Semiquincentennial
2026-05-18 21:29
5441
